Back Pain & Disc Degeneration stem cell therapy — your questions answered (2026)

About stem cell therapy for Back Pain & Disc Degeneration

Back pain is a symptom with muscular, joint, disc, nerve, inflammatory, fracture, infection, cancer and visceral causes. Intradiscal, epidural, facet, paraspinal or intravenous cell and exosome procedures have different targets and risks. A disc-regeneration mechanism in a laboratory does not establish pain relief, neurological recovery or avoidance of surgery.

The evidence for Back Pain & Disc Degeneration

Before research is considered, identify red flags and the anatomical diagnosis; imaging findings alone may not explain symptoms. Product studies must match source, processing, dose, route, comparator, diagnosis and validated pain and function outcomes. The FDA consumer alert states that the promoted regenerative products it addresses have not been approved in the United States for disc disease or back pain.

Request an itemised quote for diagnosis, product, imaging guidance, anaesthesia, facility, rehabilitation, follow-up and management of infection, bleeding, nerve injury or worsening pain. Compare with evidence-based conservative care and indicated specialist or surgical review, not with a promise to avoid surgery.

Can stem cells repair spinal discs?

Cell therapy for Back Pain & Disc Degeneration may be offered as an individualised programme, but regulatory status depends on the product, processing, indication and jurisdiction. It is currently investigational. Verify authorisation status, cell source, release testing and clinical evidence for the specific proposal.

Is it an alternative to fusion surgery?

Schedules vary by the exact product, protocol, route, monitoring needs and clinical context. Request the proposed schedule and its evidence before making travel arrangements.

How is it injected?

Eligibility depends on the protocol's inclusion and exclusion criteria and an appropriately qualified clinician's assessment. An online checklist cannot determine candidacy or replace medical advice.

EU cost?

The partner-published indicative range for an Back Pain & Disc Degeneration programme is €3,000–€8,000 for treatment. Request a current written quotation and compare product, dose, visits, inclusions and follow-up before using country ranges as a benchmark.

Sources & further reading

We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.

• Open clinical trials for Back Pain & Disc Degeneration (ClinicalTrials.gov) ↗
• Peer-reviewed research on PubMed ↗
• ISSCR patient guide — what to ask ↗
• FDA consumer warning on stem-cell therapies ↗
• EMA — advanced-therapy (ATMP) framework ↗

← Back to Back Pain & Disc Degeneration overview · Back Pain & Disc Degeneration cost →